UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 193

Sortiert nach

Artificial intelligence in cardiology

Revista Medico-Chirurgicala, 2023-06, Vol.127 (2), p.163-169

Apetrei, E.

2023

Volltextzugriff (PDF)

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

The New England journal of medicine, 2013-11, Vol.369 (22), p.2093-2104

2013

Volltextzugriff (PDF)

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2008-09, Vol.372 (9641), p.807-816

2008

Volltextzugriff (PDF)

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)

Circulation. Arrhythmia and electrophysiology, 2017-01, Vol.10 (1), p.e004267-e004267

2017

Volltextzugriff (PDF)

Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

Stroke (1970), 2016-08, Vol.47 (8), p.2075-2082

2016

Volltextzugriff (PDF)

Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals

European heart journal, 2012-03, Vol.33 (5), p.587-594

2012

Volltextzugriff (PDF)

Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48

Clinical cardiology (Mahwah, N.J.), 2016-06, Vol.39 (6), p.345-346

2016

Volltextzugriff (PDF)

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

European journal of heart failure, 2009-08, Vol.11 (8), p.795-801

2009

Volltextzugriff (PDF)

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

Stroke (1970), 2014-08, Vol.45 (8), p.2372-2378

2014

Volltextzugriff (PDF)

The role of European national journals in education

Heart (British Cardiac Society), 2009-12, Vol.95 (24), p.e3-e3

2009

Volltextzugriff (PDF)

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

European heart journal. Quality of care & clinical outcomes, 2023-01, Vol.9 (1), p.42-53

2023

Volltextzugriff (PDF)

P1623 Validation of the RECPAM in-hospital risk score after acute myocardial infarction myocardial infarction: follow-up of 537 patients

European heart journal, 2003-03, Vol.24 (5), p.300

APETREI, E

2003

Volltextzugriff (PDF)

Cardiac tumors: the experience of a tertiary cardiology center

Revue roumaine de médecine interne (1990), 2007, Vol.45 (4), p.333

2007

Volltextzugriff (PDF)

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

ESC Heart Failure, 2021-02, Vol.8 (1), p.95-105

2021

Volltextzugriff (PDF)

Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?

Revue roumaine de médecine interne (1990), 2005, Vol.43 (3-4), p.199

2005

Volltextzugriff (PDF)

The prevalence of major cardiovascular risk factors in a Roma ethnic sample population

European heart journal, 2013-08, Vol.34 (suppl 1), p.P2540-P2540

2013

Volltextzugriff (PDF)

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

Journal of the American Heart Association, 2017-08, Vol.6 (8), p.n/a

2017

Volltextzugriff (PDF)

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study

Clinical therapeutics, 2008-03, Vol.30 (3), p.482-498

2008

Volltextzugriff (PDF)

C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation

Revue roumaine de médecine interne (1990), 2004, Vol.42 (1), p.95

2004

Volltextzugriff (PDF)

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

The Lancet (British edition), 2000-01, Vol.355 (9201), p.337-345

The SYMPHONY Investigators

2000

Volltextzugriff (PDF)

New insights into the pathogenesis and prognosis of aortic sclerosis

Revue roumaine de médecine interne (1990), 2004, Vol.42 (3), p.635

2004

Volltextzugriff (PDF)

Subclinical atherosclerosis, carotid intima-media thickness and the cardiovascular risk

Revue roumaine de médecine interne (1990), 2003, Vol.41 (4), p.357

2003

Volltextzugriff (PDF)

Romanian hypertrophic cardiomyopathy registry: Profile of patients included between 2014–2017

Archives of Cardiovascular Diseases Supplements, 2018-01, Vol.10 (1), p.37-38

2018

Volltextzugriff (PDF)

Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals

Heart (British Cardiac Society), 2012-04, Vol.98 (7), p.e1-e7

2012

Volltextzugriff (PDF)

Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

European heart journal, 2000-12, Vol.21 (24), p.2005-2013

InTIME-II Investigators

2000

Volltextzugriff (PDF)

1 – 25 von 193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(101)
Humans
(83)
Life Sciences & Biomedicine
(65)
Male
(49)
Female
(46)
Cardiac & Cardiovascular Systems
(36)
Cardiovascular System & Cardiology
(35)
Middle Aged
(33)
Adult
(32)
Human Immunodeficiency Virus
(30)
Hiv
(27)
Aged
(25)
Europe
(25)
Biological And Medical Sciences
(22)
Animals
(21)
Science & Technology - Other Topics
(21)
Acquired Immune Deficiency Syndrome
(20)
Aids
(20)
Infections
(20)
Multidisciplinary Sciences
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Artificial intelligence in cardiology

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48)

Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events: Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals

Cardioversion of Atrial Fibrillation in ENGAGE AF‐TIMI 48

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

The role of European national journals in education

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

P1623 Validation of the RECPAM in-hospital risk score after acute myocardial infarction myocardial infarction: follow-up of 537 patients

Cardiac tumors: the experience of a tertiary cardiology center

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

Is interleukin-18 correlated with endothelial dysfunction and platelet activation in patients with unstable angina?

The prevalence of major cardiovascular risk factors in a Roma ethnic sample population

Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: A 3-year, randomized, multicenter, double-blind, placebo-controlled study

C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation

Comparison of sibrafiban with aspirin for prevention of cardiovascular events after acute coronary syndromes: a randomised trial

New insights into the pathogenesis and prognosis of aortic sclerosis

Subclinical atherosclerosis, carotid intima-media thickness and the cardiovascular risk

Romanian hypertrophic cardiomyopathy registry: Profile of patients included between 2014–2017

Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals

Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction

Suchergebnisse filtern